What is the usual dosage for Tazocin (piperacillin and tazobactam) in adults with normal renal function and in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tazocin (Piperacillin/Tazobactam) Usual Dosage

For adults with normal renal function and serious infections, the standard dose is 3.375g IV every 6 hours (total 13.5g daily), administered as an extended infusion over 3-4 hours rather than a standard 30-minute bolus. 1, 2

Adult Dosing by Clinical Indication

Standard Infections (Intra-abdominal, UTI, Skin/Soft Tissue, Gynecologic)

  • 3.375g IV every 6 hours (total 13.5g daily) administered over 3-4 hours 1, 2
  • This provides 12g piperacillin and 1.5g tazobactam daily 1

Nosocomial Pneumonia and Severe Pseudomonal Infections

  • 4.5g IV every 6 hours (total 18g daily) administered over 3-4 hours 1, 2
  • This provides 16g piperacillin and 2g tazobactam daily 1
  • The higher dose is critical for infections with elevated MICs or Pseudomonas aeruginosa 2, 3
  • Should be combined with an aminoglycoside for initial empiric therapy of nosocomial pneumonia 1

Extended Infusion Rationale

Extended infusion over 3-4 hours is strongly preferred over standard 30-minute infusions because:

  • Beta-lactams exhibit time-dependent killing, requiring plasma concentrations above the MIC for 60-70% of the dosing interval for moderate infections and ideally 100% for severe infections 2, 3
  • Meta-analyses demonstrate reduced mortality (RR 0.70) in critically ill septic patients receiving extended/continuous infusions versus intermittent bolus 2
  • Patients with APACHE II ≥20 show particular benefit with improved clinical cure rates 2

Pediatric Dosing (≥2 Months of Age)

Children 2-9 Months

  • Appendicitis/Peritonitis: 90 mg/kg (80 mg piperacillin/10 mg tazobactam) every 8 hours 1
  • Nosocomial Pneumonia: 90 mg/kg every 6 hours 1

Children >9 Months (up to 40 kg)

  • Appendicitis/Peritonitis: 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam) every 8 hours 1
  • Nosocomial Pneumonia: 112.5 mg/kg every 6 hours 1

Alternative Pediatric Dosing Framework

  • 200-300 mg/kg/day of piperacillin component divided every 6-8 hours for complicated intra-abdominal infections 4
  • Maximum doses should not exceed adult dosing 4

Renal Impairment Dosing

Creatinine Clearance ≤40 mL/min

  • Dosage reduction is required based on degree of renal impairment 1, 5
  • Loading doses remain unchanged; only maintenance doses require adjustment 2

Hemodialysis

  • Hemodialysis removes 31% of piperacillin and 39% of tazobactam 5
  • Supplemental dosing after dialysis sessions is necessary 5

Continuous Renal Replacement Therapy (CRRT)

  • Therapeutic drug monitoring is strongly recommended due to significant pharmacokinetic variability 2
  • Patients with residual CrCl >50 mL/min may have fivefold higher clearance compared to those with CrCl <10 mL/min, even while on CRRT 2

Critical Care and Septic Shock Considerations

Loading Dose Strategy

  • Administer 4.5g as the first dose over 3-4 hours to rapidly achieve therapeutic levels in patients with expanded extracellular volume from fluid resuscitation 2
  • Loading doses are not affected by renal function 2

Maintenance Dosing

  • 4.5g every 6 hours as extended infusion for septic shock 2, 3
  • Target piperacillin trough concentration of 33-64 mg/L for optimal outcomes 2
  • Consider therapeutic drug monitoring within 24-48 hours in critically ill patients 2

Common Pitfalls to Avoid

Do not use standard 30-minute infusions in critically ill or septic patients—this fails to maintain adequate drug concentrations throughout the dosing interval and is associated with worse outcomes 2

Do not underdose at 3.375g every 6 hours for sepsis or nosocomial pneumonia—this lower dose is appropriate for less severe community-acquired infections but inadequate for septic patients, especially with Pseudomonas risk 2

Do not reduce dosing frequency to every 8 hours based solely on clinical improvement—maintain appropriate frequency until treatment completion 3

Monitor renal function closely in critically ill patients—piperacillin/tazobactam is an independent risk factor for acute kidney injury in this population, particularly at higher doses (4.5g) 1, 6

Duration of Therapy

  • 4-7 days for most complicated intra-abdominal infections when adequate source control is achieved 2
  • Longer durations are not associated with improved outcomes 2

References

Guideline

Piperacillin/Tazobactam Dosing Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Piperacillin-Tazobactam Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.